company background image
4737 logo

Bionime TWSE:4737 Stock Report

Last Price

NT$68.80

Market Cap

NT$4.2b

7D

-0.1%

1Y

-7.9%

Updated

26 Apr, 2024

Data

Company Financials +

4737 Stock Overview

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally.

4737 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance1/6
Financial Health1/6
Dividends2/6

Bionime Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bionime
Historical stock prices
Current Share PriceNT$68.80
52 Week HighNT$90.10
52 Week LowNT$67.20
Beta0.59
1 Month Change0.58%
3 Month Change-2.27%
1 Year Change-7.90%
3 Year Change-14.32%
5 Year Change34.90%
Change since IPO2.27%

Recent News & Updates

Recent updates

These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong

Apr 29
These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong

Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?

Mar 23
Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?

Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?

Mar 05
Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?

Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?

Feb 15
Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?

Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet

Feb 01
Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet

How Has Bionime (TPE:4737) Allocated Its Capital?

Jan 19
How Has Bionime (TPE:4737) Allocated Its Capital?

A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE

Jan 06
A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE

A Look At The Fair Value Of Bionime Corporation (TPE:4737)

Dec 22
A Look At The Fair Value Of Bionime Corporation (TPE:4737)

Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend

Dec 09
Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend

Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment

Nov 24
Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment

Shareholder Returns

4737TW Medical EquipmentTW Market
7D-0.1%4.1%2.8%
1Y-7.9%4.5%27.4%

Return vs Industry: 4737 underperformed the TW Medical Equipment industry which returned 7% over the past year.

Return vs Market: 4737 underperformed the TW Market which returned 27.2% over the past year.

Price Volatility

Is 4737's price volatile compared to industry and market?
4737 volatility
4737 Average Weekly Movement1.8%
Medical Equipment Industry Average Movement4.4%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.7%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 4737 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4737's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003n/aRoy Huangwww.bionime.com

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally. The company offers blood glucose monitors and self-monitors, as well as accessories, such as test strips and lancing devices for hospital and clinical use. It is also involved in the provision of biotechnology services; examining of pharmaceuticals; and selling of precision instruments.

Bionime Corporation Fundamentals Summary

How do Bionime's earnings and revenue compare to its market cap?
4737 fundamental statistics
Market capNT$4.19b
Earnings (TTM)NT$6.21m
Revenue (TTM)NT$1.76b

675.3x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4737 income statement (TTM)
RevenueNT$1.76b
Cost of RevenueNT$1.04b
Gross ProfitNT$715.65m
Other ExpensesNT$709.44m
EarningsNT$6.21m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.10
Gross Margin40.76%
Net Profit Margin0.35%
Debt/Equity Ratio140.3%

How did 4737 perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

568%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.